Miglitol - a better acarbose? Increases UCP1, decreases gastric inhibitory peptide (GIP) + decreases body weight

#1

https://dir.indiamart.com/search.mp?ss=Miglitol+&prdsrc=1

2 Likes
Tirzepatide - a better semaglutide? (GIP + GLP1 agonism). Also LY3437943
#2

One possible caveat

GIP recently appeared as a major player in bone remodeling. Researchers at Universities of Angers and Ulster evidenced that genetic ablation of the GIP receptor in mice resulted in profound alterations of bone microarchitecture through modification of the adipokine network.[14] Furthermore, the deficiency in GIP receptors has also been associated in mice with a dramatic decrease in bone quality and a subsequent increase in fracture risk.[15] However, the results obtained by these groups are far from conclusive because their animal models give discordant answers and these works should be analysed very carefully.[citation needed]

1 Like
#3

cheaper than acarbose here, wow. except, out of stock

2 Likes
#4

It’s on mark Cuban’$

#5

Favor miglitol when

  • Your CGM spike is concentrated in the first 30–90 minutes. In a tiny randomized crossover study, miglitol 50 mg suppressed the early rise more than acarbose 100 mg, although peak glucose and total three-hour glucose exposure were not significantly different. So miglitol may reshape the curve rather than reduce the total carbohydrate absorbed. Evidence is limited and comes from people with type 2 diabetes.
  • Acarbose causes excessive gas, bloating, or constipation. A small crossover study found more flatus and early bloating with acarbose; miglitol produced softer stools and was therefore worse for people already prone to diarrhea.
  • You want to avoid acarbose’s liver-enzyme issue. Acarbose can cause dose-related transaminase elevations and its current label recommends liver testing, particularly above 50 mg three times daily. Miglitol is not metabolized and does not carry the same liver-monitoring instruction.

Favor acarbose when

  • The meal is heavily starch-based. Acarbose inhibits both pancreatic α-amylase, which begins starch breakdown, and intestinal α-glucosidases. Miglitol primarily inhibits the brush-border α-glucosidases. Rice, bread, potatoes, pasta, and similar human starch constructions therefore give acarbose a mechanistic advantage.
  • You tend toward loose stools or diarrhea.
  • Kidney function is impaired. Miglitol is substantially absorbed and eliminated unchanged by the kidneys; significant renal dysfunction makes it a poorer choice. Acarbose is less than 2% systemically absorbed as active drug, although its label also discourages use in significant renal dysfunction.